Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma
Phase 1
Completed
- Conditions
- High Grade Glioma
- Interventions
- Drug: 5 Aminolevulinic AcidDevice: CV01-delivered ultrasound
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Alpheus Medical, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT05362409
- Locations
- 🇺🇸
Washington University School of Medicine in St.Louis, Saint Louis, Missouri, United States
🇺🇸Dent Neurosciences Research Center, Amherst, New York, United States
🇺🇸Northwell, Lake Success, New York, United States
News
No news found